Skip to content

Metagenomi Inc Sustainability Reports

Metagenomi, Inc. is a gene-editing biotechnology company that develops next-generation genetic medicines. The company leverages machine learning and a metagenomics-derived genome editing toolbox to discover and build programmable cellular therapies for patients.

Sector: Professional & technical services

Country: United States

Exchange: Nasdaq

FIGI: BBG00Y5ZXS95

No reports are currently available in our catalogue.